Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Renal Insufficiency, Chronic 1Polycystic Kidney, Autosomal Dominant 1Hypertension 1Hematologic Neoplasms 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Polymorphism, Genetic × Genitourinary × Clear all
NCT06416761 2024-05-16

Genetics in the Progression of Nephropathies

Ospedale San Raffaele

Recruiting
10,000 enrolled
GenitourinaryOther hematologic neoplasm

Hypertension, Chronic Kidney Disease-Mineral and Bone Disorder, Polycystic Kidney, Autosomal Dominant, Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡